APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gynecological Chinese Medicine Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gynecological Chinese Medicine Injection Market Outlook and Growth Opportunities 2026

23 December 2025198 pages

Choose your research edition.

Industry ResearchGynecological Chinese Medicine Injection Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Gynecological Chinese Medicine Injection Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Gynecological Chinese Medicine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gynecological Chinese Medicine Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Gynecological Chinese Medicine Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gynecological Chinese Medicine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gynecological Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gynecological Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gynecological Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gynecological Chinese Medicine Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gynecological Chinese Medicine Injection market include Chengdu First Pharmaceutical, Fujian Gutian Pharmaceutical, China Resources Sanjiu, Jiangsu Hengfeng Pharmaceuticals and Kanion Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gynecological Chinese Medicine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gynecological Chinese Medicine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gynecological Chinese Medicine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gynecological Chinese Medicine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Gynecological Chinese Medicine Injection Segment by Company

Chengdu First Pharmaceutical

Fujian Gutian Pharmaceutical

China Resources Sanjiu

Jiangsu Hengfeng Pharmaceuticals

Kanion Pharmaceutical

Gynecological Chinese Medicine Injection Segment by Type

Motherwort Injection

Compound Angelica Injection

Other

Gynecological Chinese Medicine Injection Segment by Application

Secondary Hospital

Tertiary Hospital

Other

Gynecological Chinese Medicine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gynecological Chinese Medicine Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gynecological Chinese Medicine Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gynecological Chinese Medicine Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Gynecological Chinese Medicine Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gynecological Chinese Medicine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gynecological Chinese Medicine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gynecological Chinese Medicine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gynecological Chinese Medicine Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gynecological Chinese Medicine Injection industry.

Chapter 3: Detailed analysis of Gynecological Chinese Medicine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gynecological Chinese Medicine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gynecological Chinese Medicine Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gynecological Chinese Medicine Injection Industry Trends Table 2. Gynecological Chinese Medicine Injection Industry Drivers Table 3. Gynecological Chinese Medicine Injection Industry Opportunities and Challenges Table 4. Gynecological Chinese Medicine Injection Industry Restraints Table 5. Global Gynecological Chinese Medicine Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gynecological Chinese Medicine Injection Revenue Share by Company (2021-2026) Table 7. Global Gynecological Chinese Medicine Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Gynecological Chinese Medicine Injection Sales Volume Share by Company (2021-2026) Table 9. Global Gynecological Chinese Medicine Injection Average Price (USD/unit) of Company (2021-2026) Table 10. Global Gynecological Chinese Medicine Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gynecological Chinese Medicine Injection Key Company Manufacturing Base & Headquarters Table 12. Global Gynecological Chinese Medicine Injection Company, Product Type & Application Table 13. Global Gynecological Chinese Medicine Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gynecological Chinese Medicine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Motherwort Injection Table 18. Significant Companies of Compound Angelica Injection Table 19. Significant Companies of Other Table 20. Global Gynecological Chinese Medicine Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Gynecological Chinese Medicine Injection Sales Volume by Type (2021-2026) & (k units) Table 22. Global Gynecological Chinese Medicine Injection Sales Volume by Type (2027-2032) & (k units) Table 23. Global Gynecological Chinese Medicine Injection Sales Volume Share by Type (2021-2026) Table 24. Global Gynecological Chinese Medicine Injection Sales Volume Share by Type (2027-2032) Table 25. Global Gynecological Chinese Medicine Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gynecological Chinese Medicine Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Gynecological Chinese Medicine Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Gynecological Chinese Medicine Injection Sales Value Share by Type (2021-2026) Table 29. Global Gynecological Chinese Medicine Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Secondary Hospital Table 31. Significant Companies of Tertiary Hospital Table 32. Significant Companies of Other Table 33. Global Gynecological Chinese Medicine Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Gynecological Chinese Medicine Injection Sales Volume by Application (2021-2026) & (k units) Table 35. Global Gynecological Chinese Medicine Injection Sales Volume by Application (2027-2032) & (k units) Table 36. Global Gynecological Chinese Medicine Injection Sales Volume Share by Application (2021-2026) Table 37. Global Gynecological Chinese Medicine Injection Sales Volume Share by Application (2027-2032) Table 38. Global Gynecological Chinese Medicine Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gynecological Chinese Medicine Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Gynecological Chinese Medicine Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Gynecological Chinese Medicine Injection Sales Value Share by Application (2021-2026) Table 42. Global Gynecological Chinese Medicine Injection Sales Value Share by Application (2027-2032) Table 43. Global Gynecological Chinese Medicine Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Gynecological Chinese Medicine Injection Sales by Region (2021-2026) & (k units) Table 45. Global Gynecological Chinese Medicine Injection Sales Market Share by Region (2021-2026) Table 46. Global Gynecological Chinese Medicine Injection Sales by Region (2027-2032) & (k units) Table 47. Global Gynecological Chinese Medicine Injection Sales Market Share by Region (2027-2032) Table 48. Global Gynecological Chinese Medicine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gynecological Chinese Medicine Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Gynecological Chinese Medicine Injection Sales Value Share by Region (2021-2026) Table 51. Global Gynecological Chinese Medicine Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Gynecological Chinese Medicine Injection Sales Value Share by Region (2027-2032) Table 53. Global Gynecological Chinese Medicine Injection Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Gynecological Chinese Medicine Injection Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Gynecological Chinese Medicine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Gynecological Chinese Medicine Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Gynecological Chinese Medicine Injection Sales by Country (2021-2026) & (k units) Table 58. Global Gynecological Chinese Medicine Injection Sales Market Share by Country (2021-2026) Table 59. Global Gynecological Chinese Medicine Injection Sales by Country (2027-2032) & (k units) Table 60. Global Gynecological Chinese Medicine Injection Sales Market Share by Country (2027-2032) Table 61. Global Gynecological Chinese Medicine Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Gynecological Chinese Medicine Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Gynecological Chinese Medicine Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Gynecological Chinese Medicine Injection Sales Value Market Share by Country (2027-2032) Table 65. Chengdu First Pharmaceutical Company Information Table 66. Chengdu First Pharmaceutical Business Overview Table 67. Chengdu First Pharmaceutical Gynecological Chinese Medicine Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Chengdu First Pharmaceutical Gynecological Chinese Medicine Injection Product Portfolio Table 69. Chengdu First Pharmaceutical Recent Development Table 70. Fujian Gutian Pharmaceutical Company Information Table 71. Fujian Gutian Pharmaceutical Business Overview Table 72. Fujian Gutian Pharmaceutical Gynecological Chinese Medicine Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Fujian Gutian Pharmaceutical Gynecological Chinese Medicine Injection Product Portfolio Table 74. Fujian Gutian Pharmaceutical Recent Development Table 75. China Resources Sanjiu Company Information Table 76. China Resources Sanjiu Business Overview Table 77. China Resources Sanjiu Gynecological Chinese Medicine Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. China Resources Sanjiu Gynecological Chinese Medicine Injection Product Portfolio Table 79. China Resources Sanjiu Recent Development Table 80. Jiangsu Hengfeng Pharmaceuticals Company Information Table 81. Jiangsu Hengfeng Pharmaceuticals Business Overview Table 82. Jiangsu Hengfeng Pharmaceuticals Gynecological Chinese Medicine Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Jiangsu Hengfeng Pharmaceuticals Gynecological Chinese Medicine Injection Product Portfolio Table 84. Jiangsu Hengfeng Pharmaceuticals Recent Development Table 85. Kanion Pharmaceutical Company Information Table 86. Kanion Pharmaceutical Business Overview Table 87. Kanion Pharmaceutical Gynecological Chinese Medicine Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Kanion Pharmaceutical Gynecological Chinese Medicine Injection Product Portfolio Table 89. Kanion Pharmaceutical Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Gynecological Chinese Medicine Injection Distributors List Table 93. Gynecological Chinese Medicine Injection Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Gynecological Chinese Medicine Injection Product Image Figure 2. Global Gynecological Chinese Medicine Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gynecological Chinese Medicine Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gynecological Chinese Medicine Injection Sales (2021-2032) & (k units) Figure 5. Global Gynecological Chinese Medicine Injection Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Gynecological Chinese Medicine Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Motherwort Injection Image Figure 10. Compound Angelica Injection Image Figure 11. Other Image Figure 12. Global Gynecological Chinese Medicine Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Gynecological Chinese Medicine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Gynecological Chinese Medicine Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Gynecological Chinese Medicine Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Gynecological Chinese Medicine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Gynecological Chinese Medicine Injection Sales Value Share by Type (2021-2032) Figure 18. Secondary Hospital Image Figure 19. Tertiary Hospital Image Figure 20. Other Image Figure 21. Global Gynecological Chinese Medicine Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Gynecological Chinese Medicine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Gynecological Chinese Medicine Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Gynecological Chinese Medicine Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Gynecological Chinese Medicine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Gynecological Chinese Medicine Injection Sales Value Share by Application (2021-2032) Figure 27. Global Gynecological Chinese Medicine Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Gynecological Chinese Medicine Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Gynecological Chinese Medicine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Gynecological Chinese Medicine Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Gynecological Chinese Medicine Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Gynecological Chinese Medicine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Gynecological Chinese Medicine Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Gynecological Chinese Medicine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Gynecological Chinese Medicine Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Gynecological Chinese Medicine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Gynecological Chinese Medicine Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Gynecological Chinese Medicine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Gynecological Chinese Medicine Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Gynecological Chinese Medicine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Gynecological Chinese Medicine Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Gynecological Chinese Medicine Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Motherwort Injection
  • Compound Angelica Injection
  • Other
Applications
  • Secondary Hospital
  • Tertiary Hospital
  • Other
Companies covered
  • Chengdu First Pharmaceutical
  • Fujian Gutian Pharmaceutical
  • China Resources Sanjiu
  • Jiangsu Hengfeng Pharmaceuticals
  • Kanion Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gynecological Chinese Medicine Injection Sales Value (2021-2032)
  4. 1.2.2 Global Gynecological Chinese Medicine Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Gynecological Chinese Medicine Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gynecological Chinese Medicine Injection Market Dynamics
  1. 2.1 Gynecological Chinese Medicine Injection Industry Trends
  2. 2.2 Gynecological Chinese Medicine Injection Industry Drivers
  3. 2.3 Gynecological Chinese Medicine Injection Industry Opportunities and Challenges
  4. 2.4 Gynecological Chinese Medicine Injection Industry Restraints
3 Gynecological Chinese Medicine Injection Market by Company
  1. 3.1 Global Gynecological Chinese Medicine Injection Company Revenue Ranking in 2025
  2. 3.2 Global Gynecological Chinese Medicine Injection Revenue by Company (2021-2026)
  3. 3.3 Global Gynecological Chinese Medicine Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Gynecological Chinese Medicine Injection Average Price by Company (2021-2026)
  5. 3.5 Global Gynecological Chinese Medicine Injection Company Ranking (2024-2026)
  6. 3.6 Global Gynecological Chinese Medicine Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Gynecological Chinese Medicine Injection Company Product Type and Application
  8. 3.8 Global Gynecological Chinese Medicine Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gynecological Chinese Medicine Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gynecological Chinese Medicine Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gynecological Chinese Medicine Injection Market by Type
  1. 4.1 Gynecological Chinese Medicine Injection Type Introduction
  2. 4.1.1 Motherwort Injection
  3. 4.1.2 Compound Angelica Injection
  4. 4.1.3 Other
  5. 4.2 Global Gynecological Chinese Medicine Injection Sales Volume by Type
  6. 4.2.1 Global Gynecological Chinese Medicine Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gynecological Chinese Medicine Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Gynecological Chinese Medicine Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Gynecological Chinese Medicine Injection Sales Value by Type
  10. 4.3.1 Global Gynecological Chinese Medicine Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Gynecological Chinese Medicine Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Gynecological Chinese Medicine Injection Sales Value Share by Type (2021-2032)
5 Gynecological Chinese Medicine Injection Market by Application
  1. 5.1 Gynecological Chinese Medicine Injection Application Introduction
  2. 5.1.1 Secondary Hospital
  3. 5.1.2 Tertiary Hospital
  4. 5.1.3 Other
  5. 5.2 Global Gynecological Chinese Medicine Injection Sales Volume by Application
  6. 5.2.1 Global Gynecological Chinese Medicine Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gynecological Chinese Medicine Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gynecological Chinese Medicine Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gynecological Chinese Medicine Injection Sales Value by Application
  10. 5.3.1 Global Gynecological Chinese Medicine Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gynecological Chinese Medicine Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gynecological Chinese Medicine Injection Sales Value Share by Application (2021-2032)
6 Gynecological Chinese Medicine Injection Regional Sales and Value Analysis
  1. 6.1 Global Gynecological Chinese Medicine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gynecological Chinese Medicine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Gynecological Chinese Medicine Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Gynecological Chinese Medicine Injection Sales by Region (2027-2032)
  5. 6.3 Global Gynecological Chinese Medicine Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gynecological Chinese Medicine Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gynecological Chinese Medicine Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gynecological Chinese Medicine Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Gynecological Chinese Medicine Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gynecological Chinese Medicine Injection Sales Value (2021-2032)
  12. 6.6.2 North America Gynecological Chinese Medicine Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gynecological Chinese Medicine Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Gynecological Chinese Medicine Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gynecological Chinese Medicine Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gynecological Chinese Medicine Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gynecological Chinese Medicine Injection Sales Value (2021-2032)
  21. 6.9.2 South America Gynecological Chinese Medicine Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gynecological Chinese Medicine Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gynecological Chinese Medicine Injection Sales Value Share by Country, 2025 VS 2032
7 Gynecological Chinese Medicine Injection Country-level Sales and Value Analysis
  1. 7.1 Global Gynecological Chinese Medicine Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gynecological Chinese Medicine Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gynecological Chinese Medicine Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Gynecological Chinese Medicine Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Gynecological Chinese Medicine Injection Sales by Country (2027-2032)
  6. 7.4 Global Gynecological Chinese Medicine Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gynecological Chinese Medicine Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gynecological Chinese Medicine Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gynecological Chinese Medicine Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gynecological Chinese Medicine Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gynecological Chinese Medicine Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chengdu First Pharmaceutical
  2. 8.1.1 Chengdu First Pharmaceutical Company Information
  3. 8.1.2 Chengdu First Pharmaceutical Business Overview
  4. 8.1.3 Chengdu First Pharmaceutical Gynecological Chinese Medicine Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chengdu First Pharmaceutical Gynecological Chinese Medicine Injection Product Portfolio
  6. 8.1.5 Chengdu First Pharmaceutical Recent Developments
  7. 8.2 Fujian Gutian Pharmaceutical
  8. 8.2.1 Fujian Gutian Pharmaceutical Company Information
  9. 8.2.2 Fujian Gutian Pharmaceutical Business Overview
  10. 8.2.3 Fujian Gutian Pharmaceutical Gynecological Chinese Medicine Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fujian Gutian Pharmaceutical Gynecological Chinese Medicine Injection Product Portfolio
  12. 8.2.5 Fujian Gutian Pharmaceutical Recent Developments
  13. 8.3 China Resources Sanjiu
  14. 8.3.1 China Resources Sanjiu Company Information
  15. 8.3.2 China Resources Sanjiu Business Overview
  16. 8.3.3 China Resources Sanjiu Gynecological Chinese Medicine Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 China Resources Sanjiu Gynecological Chinese Medicine Injection Product Portfolio
  18. 8.3.5 China Resources Sanjiu Recent Developments
  19. 8.4 Jiangsu Hengfeng Pharmaceuticals
  20. 8.4.1 Jiangsu Hengfeng Pharmaceuticals Company Information
  21. 8.4.2 Jiangsu Hengfeng Pharmaceuticals Business Overview
  22. 8.4.3 Jiangsu Hengfeng Pharmaceuticals Gynecological Chinese Medicine Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengfeng Pharmaceuticals Gynecological Chinese Medicine Injection Product Portfolio
  24. 8.4.5 Jiangsu Hengfeng Pharmaceuticals Recent Developments
  25. 8.5 Kanion Pharmaceutical
  26. 8.5.1 Kanion Pharmaceutical Company Information
  27. 8.5.2 Kanion Pharmaceutical Business Overview
  28. 8.5.3 Kanion Pharmaceutical Gynecological Chinese Medicine Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kanion Pharmaceutical Gynecological Chinese Medicine Injection Product Portfolio
  30. 8.5.5 Kanion Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gynecological Chinese Medicine Injection Value Chain Analysis
  2. 9.1.1 Gynecological Chinese Medicine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gynecological Chinese Medicine Injection Sales Mode & Process
  6. 9.2 Gynecological Chinese Medicine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gynecological Chinese Medicine Injection Distributors
  9. 9.2.3 Gynecological Chinese Medicine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst